[1]. Ubiquitin-like 3 as a new protein-sorting factor for small extracellular vesicles.
Cell structure and function [Volume]47 [Issue]1 [Page]1 -18 (2022/)
[DOI] [2]. 乳癌患者の妊娠・出産と生殖医療に関する診療ガイドライン改訂のポイント(乳癌関連)
日本がん・生殖医療学会誌 (一社)日本がん・生殖医療学会 [Volume]5 [Issue]1 [Page]16 -22 (2022/)
[3]. A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report
[Volume]7 [Issue]1 [Page]16 (2021/) [Reviewed] Yes
[4]. A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report
Surg Case Rep . [Volume]7 [Issue]1 [Page]16 (2021/) [Reviewed] Yes
[5]. Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
Trials [Volume]21 [Issue]1 [Page]391391 (2020/) [Reviewed] Yes